Your Article Summary
See Latest ArticlesExpression of multidrug resistance markers ABCB1 (MDR-1/ Pgp) and ABCC1 (MRP-1) in renal cell carcinoma
BMC Urology, 06/25/09
Walsh N et al. - Although these findings do not prove a causal role, the high frequency of tumours expressing these efflux pumps suggests that they may be important contributors to the chemoresistance of this tumour type.
Related Articles
Clinical Characteristics of Renal Cell Carcinoma in Korean Patients with von Hippel-Lindau Disease Compared to Sporadic Bilateral or Multifocal Renal Cell Carcinoma
Journal of Korean Medical Science, 11/16/09
Relevance Score: 84%
Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era
European Urology, 11/03/09
Relevance Score: 84%
Population-based survey of cancer risks in chromosome 3 translocation carriers
Genes, Chromosomes and Cancer, 10/28/09
Relevance Score: 84%
Apolipoprotein E/C1 Locus Variants Modify Renal Cell Carcinoma Risk
Cancer Research, 10/20/09
Relevance Score: 84%
Surgical Treatment of Renal Cell Carcinoma in the Immunocompromised Transplant Patient
Urology, 10/12/09
Relevance Score: 84%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Management for Patients with De Novo or Recurrent Tumors in the Residual Kidney after Surgery for Nonfamilial Bilateral Renal Cell Carcinoma
Advances in Urology, 12/01/09
Tacrolimus enhances transforming growth factor-[beta]1 expression and promotes tumor progression
Transplantation, 12/01/09
The Motion: Cryotherapy is an Efficient Alternative for Kidney Cancer
European Urology, 11/30/09